Borlaug Infection

Borlaug Infection Prevention Services appears to be a healthcare consulting business focused on infection prevention rather than a drug-development biotech or pharmaceutical company. Public references identify Gwen Borlaug as an infection prevention consultant associated with Borlaug Infection Prevention Services/Borlaug Infection, including conference and industry materials related to hospital infection control and nasal decolonization programs. The organization appears to provide professional consulting services to healthcare providers on infection prevention practices and reduction of healthcare-associated infections such as MRSA and Staphylococcus aureus. I found no evidence of a therapeutic pipeline, proprietary drug candidates, public-market listing, or broad corporate infrastructure typical of a biotech or pharma company.